Analytical and Structural chemistry, CSIR- Indian Institute of Chemical Technology, Hyderabad, India in association with the Biotech Research Society, India (BRSI) and IBA- International Forum for Industrial Bioprocesses (IBA- IFIBiop), France, Hyderabad, India
Dr. Alegete Pallavi
Analytical and Structural chemistry, CSIR- Indian Institute of Chemical Technology, Hyderabad, India in association with the Biotech Research Society, India (BRSI) and IBA- International Forum for Industrial Bioprocesses (IBA- IFIBiop), France, Hyderabad, India
For the first time a new QbD-assisted green stability indicating ultra-high-performance liquid chromatography (UHPLC) method was developed and validated for quantifying Tolvaptan. The method is simple, quick, cost-effective, and stable, and it was used to formulate a quality target product profile (QTPP) with strategically defined critical analytical attributes (CAAs) to meet specific criteria. Chromatographic separation was undertaken using a 10 cm long column of ACE excel super C18 with an interior diameter of 2.1 mm and particle size of 1.7 µm. The analysis was performed under controlled conditions at 25 ℃ with the mobile phase flowing at a rate of 0.2 mL/min and detection occurring at 220 nm. Injected 3 µL of standard by using an isocratic mobile phase system consisting of acetonitrile and water in a 95:5 v/v ratio. The diluents, prepared by mixing acetonitrile with water at a 90:10 volumetric ratio, were utilized. The analyte’s retention time was determined to be 1.63 min. The developed method provided reliable results with accuracy exceeding 99% and a correlation coefficient exceeding 0.999 ranged between 10 and 150 µg/mL across the range for LOQ—150% levels. Notably, during forced degradation testing, Tolvaptan exhibited susceptibility to acidic hydrolysis. The method effectively separated degradation products during stress testing, demonstrating its stability-indicating status. Environmental sustainability assessment of the developed method was conducted through the investigation of various indicators of Complex GAPI, Analytical Eco scale and Analytical GREEness and it was concluded the optimized method aligns with environmentally friendly practices.
This study reports the development and validation of a novel ultra-high-performance liquid chromatography (UHPLC) method that is both stability indicating and environmentally sustainable, intended for the simultaneous quantification of tezacaftor (TZF) and ivacaftor (IVF) in pharmaceutical formulations. Using analytical quality-by-design (AQbD) principles, critical method parameters (CMPs), including flow rate and column temperature, were optimized using central composite design (CCD). Separation was achieved on an ACE Excel Super C18 column (100 × 2.1 mm, 2 µm) using an isocratic mobile phase of acetonitrile and water at 75 : 25 v/v, 0.3 ml min−1 , with detection at 254 nm. Validation according to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q2(R1) demonstrated excellent linearity (R² > 0.999), accuracy (98–102% recovery), precision (% relative standard deviation (% r.s.d.) < 2%) and sensitivity with limits of detection (LOD) and quantification (LOQ) 0.5/1.5 µg ml−1 (TZF) and 0.3/1.0 µg ml−1 (IVF). The stability-indicating nature of the method was confirmed through forced-degradation studies under various stress conditions, with peak purity analysis supporting its specificity. Sustainability assessment using the Analytical Eco-Scale (score: 80), GAPI and AGREE tools verified the method’s eco-friendly profile.